SCHEMBL4007108

SCHEMBL4007108

CC1CCC(CNS(=O)(=O)c2ccc(C(C)C)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.56
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
ALDH1A1 P00352 3/20 0.51
CYP2C9 P11712 1/20 0.51
PARG Q86W56 1/20 0.50
POLB P06746 1/20 0.50
MCOLN3 Q8TDD5 1/20 0.50
CNR2 P34972 2/20 0.48
CNR1 P21554 1/20 0.48
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
KCNH2 Q12809 2/20 0.46
HRH3 Q9Y5N1 2/20 0.46
THRB P10828 1/20 0.46
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698803 0.87 KMT2A (0.62) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL4390035 0.84 KMT2A (0.60) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL4390037 0.84 KMT2A (0.60) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL4979102 0.82 GBA1 (0.84) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7698607 0.79 KMT2A (0.58) KMT2AMEN1ALDH1A1CYP2C9POLB
SCHEMBL13590685 0.78 ACACB (0.70) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL2376303 0.77 GBA1 (0.69) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL4005870 0.76 PARG (0.52) GBA1KMT2AMEN1ALDH1A1CYP2C9
SCHEMBL14132588 0.74 ALDH1A1 (0.73) KMT2AMEN1ALDH1A1POLBLMNA
SCHEMBL3012277 0.73 GBA1 (0.69) GBA1KMT2AMEN1ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009082346-A1 NEW ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS AND USES IN TREATMENTS OF OBESITY AND DIABETES MELLITUS - 087 ASTRAZENECA AB (SE) 2009-07-02 WO disclosed